These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 32062148)

  • 41. Oxidative inactivation of amyloid beta-degrading proteases by cholesterol-enhanced mitochondrial stress.
    de Dios C; Bartolessis I; Roca-Agujetas V; Barbero-Camps E; Mari M; Morales A; Colell A
    Redox Biol; 2019 Sep; 26():101283. PubMed ID: 31376793
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Deregulation of mitochondrial F1FO-ATP synthase via OSCP in Alzheimer's disease.
    Beck SJ; Guo L; Phensy A; Tian J; Wang L; Tandon N; Gauba E; Lu L; Pascual JM; Kroener S; Du H
    Nat Commun; 2016 May; 7():11483. PubMed ID: 27151236
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Effects of Cardiotrophin-1 on Early Synaptic Mitochondrial Dysfunction and Synaptic Pathology in APPswe/PS1dE9 Mice.
    Wang D; Liu X; Liu Y; Li S; Wang C
    J Alzheimers Dis; 2017; 59(4):1255-1267. PubMed ID: 28731433
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Newly Synthesized Rhamnoside Derivative Alleviates Alzheimer's Amyloid-
    Li Y; Lu J; Cao X; Zhao H; Gao L; Xia P; Pei G
    Oxid Med Cell Longev; 2020; 2020():7698560. PubMed ID: 32104538
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Small molecules as therapeutic drugs for Alzheimer's disease.
    Oliver DMA; Reddy PH
    Mol Cell Neurosci; 2019 Apr; 96():47-62. PubMed ID: 30877034
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neurotherapeutic effects of novel HO-1 inhibitors in vitro and in a transgenic mouse model of Alzheimer's disease.
    Gupta A; Lacoste B; Pistell PJ; Ingram DK; Hamel E; Alaoui-Jamali MA; Szarek WA; Vlahakis JZ; Jie S; Song W; Schipper HM
    J Neurochem; 2014 Dec; 131(6):778-90. PubMed ID: 25111043
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease.
    Caspersen C; Wang N; Yao J; Sosunov A; Chen X; Lustbader JW; Xu HW; Stern D; McKhann G; Yan SD
    FASEB J; 2005 Dec; 19(14):2040-1. PubMed ID: 16210396
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Geniposide attenuates mitochondrial dysfunction and memory deficits in APP/PS1 transgenic mice.
    Lv C; Liu X; Liu H; Chen T; Zhang W
    Curr Alzheimer Res; 2014; 11(6):580-7. PubMed ID: 25034042
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
    Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA
    J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased Electron Paramagnetic Resonance Signal Correlates with Mitochondrial Dysfunction and Oxidative Stress in an Alzheimer's disease Mouse Brain.
    Fang D; Zhang Z; Li H; Yu Q; Douglas JT; Bratasz A; Kuppusamy P; Yan SS
    J Alzheimers Dis; 2016; 51(2):571-80. PubMed ID: 26890765
    [TBL] [Abstract][Full Text] [Related]  

  • 53. AdipoRon improves cognitive dysfunction of Alzheimer's disease and rescues impaired neural stem cell proliferation through AdipoR1/AMPK pathway.
    Liu B; Liu J; Wang JG; Liu CL; Yan HJ
    Exp Neurol; 2020 May; 327():113249. PubMed ID: 32070713
    [TBL] [Abstract][Full Text] [Related]  

  • 54. BHBA treatment improves cognitive function by targeting pleiotropic mechanisms in transgenic mouse model of Alzheimer's disease.
    Wu Y; Gong Y; Luan Y; Li Y; Liu J; Yue Z; Yuan B; Sun J; Xie C; Li L; Zhen J; Jin X; Zheng Y; Wang X; Xie L; Wang W
    FASEB J; 2020 Jan; 34(1):1412-1429. PubMed ID: 31914599
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intracellular Calcium Dysregulation: Implications for Alzheimer's Disease.
    Magi S; Castaldo P; Macrì ML; Maiolino M; Matteucci A; Bastioli G; Gratteri S; Amoroso S; Lariccia V
    Biomed Res Int; 2016; 2016():6701324. PubMed ID: 27340665
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bispecific Antibody Fragment Targeting APP and Inducing α-Site Cleavage Restores Neuronal Health in an Alzheimer's Mouse Model.
    He P; Xin W; Schulz P; Sierks MR
    Mol Neurobiol; 2019 Nov; 56(11):7420-7432. PubMed ID: 31041656
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Loss of mitofusin 2 links beta-amyloid-mediated mitochondrial fragmentation and Cdk5-induced oxidative stress in neuron cells.
    Park J; Choi H; Min JS; Kim B; Lee SR; Yun JW; Choi MS; Chang KT; Lee DS
    J Neurochem; 2015 Mar; 132(6):687-702. PubMed ID: 25359615
    [TBL] [Abstract][Full Text] [Related]  

  • 58. OAB-14, a bexarotene derivative, improves Alzheimer's disease-related pathologies and cognitive impairments by increasing β-amyloid clearance in APP/PS1 mice.
    Yuan C; Guo X; Zhou Q; Du F; Jiang W; Zhou X; Liu P; Chi T; Ji X; Gao J; Chen C; Lang H; Xu J; Liu D; Yang Y; Qiu S; Tang X; Chen G; Zou L
    Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):161-180. PubMed ID: 30389579
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dl-3-n-butylphthalide-induced upregulation of antioxidant defense is involved in the enhancement of cross talk between CREB and Nrf2 in an Alzheimer's disease mouse model.
    Wang CY; Wang ZY; Xie JW; Wang T; Wang X; Xu Y; Cai JH
    Neurobiol Aging; 2016 Feb; 38():32-46. PubMed ID: 26827641
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased neuronal PreP activity reduces Aβ accumulation, attenuates neuroinflammation and improves mitochondrial and synaptic function in Alzheimer disease's mouse model.
    Fang D; Wang Y; Zhang Z; Du H; Yan S; Sun Q; Zhong C; Wu L; Vangavaragu JR; Yan S; Hu G; Guo L; Rabinowitz M; Glaser E; Arancio O; Sosunov AA; McKhann GM; Chen JX; Yan SS
    Hum Mol Genet; 2015 Sep; 24(18):5198-210. PubMed ID: 26123488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.